FDA warns of severe vision loss associated with eye injections of a compounded drug containing vancomycin

"Raising awareness about emerging safety issues associated with compounded drugs is a top priority for the FDA's compounding program," said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research. "Just today, the FDA provided details about a case of severe vision loss associated with eye injections of a compounded drug containing ["]

The post FDA warns of severe vision loss associated with eye injections of a compounded drug containing vancomycin appeared first on Outbreak News Today.